Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.
Re-Vana Therapeutics has raised $12.1M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Re-Vana Therapeutics's investors include SyndicateRoom, MassChallenge, Techstart Ventures, Visionary Venture Fund, ExSight Ventures.
Re-Vana Therapeutics is headquartered in Belfast, United Kingdom.
Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.
Re-Vana Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Re-Vana Therapeutics — Funding & Investors." VCBacked, November 30, 2022, https://www.vcbacked.co/company/re-vana-therapeutics. Accessed August 16, 2026.
VCBacked. (2022). Re-Vana Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/re-vana-therapeutics
{{cite web |title=Re-Vana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/re-vana-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated